KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Other financing activities (2016 - 2025)

Tenet Healthcare's Other financing activities history spans 17 years, with the latest figure at $16.0 million for Q4 2025.

  • For Q4 2025, Other financing activities rose 433.33% year-over-year to $16.0 million; the TTM value through Dec 2025 reached $32.0 million, changed N/A, while the annual FY2025 figure was $32.0 million, N/A changed from the prior year.
  • Other financing activities for Q4 2025 was $16.0 million at Tenet Healthcare, down from $71.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $126.0 million in Q2 2022 and bottomed at -$102.0 million in Q1 2022.
  • The 5-year median for Other financing activities is $3.0 million (2023), against an average of $470588.2.
  • The largest YoY upside for Other financing activities was 433.33% in 2025 against a maximum downside of 700.0% in 2025.
  • A 5-year view of Other financing activities shows it stood at -$79.0 million in 2021, then soared by 259.49% to $126.0 million in 2022, then plummeted by 97.62% to $3.0 million in 2023, then changed by 0.0% to $3.0 million in 2024, then surged by 433.33% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Other financing activities are $16.0 million (Q4 2025), $71.0 million (Q3 2025), and -$16.0 million (Q2 2025).